(firstQuint)Venlafaxine Augmentation in Treatment Resistant Depression.

 We examine the efficacy of Venlafaxine-HCL augmentation with the neuroleptic Quetiapine in treatment resistant depression in a double-blind randomized clinical trial.

 Secondary objective is the evaluation of pharmacogenetic factors contributing to drug efficacy in treatment resistant depression.

.

 Venlafaxine Augmentation in Treatment Resistant Depression@highlight

This is an assessment of the efficacy of venlafaxine-HCL augmentation with the neuroleptic quetiapine in treatment resistant depression.

